These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 1697646)

  • 21. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early death.
    Büchner T; Hiddemann W; Zühlsdorf M; Koenigsmann M; Böckmann A; van de Loo J; Schulz G
    Behring Inst Mitt; 1988 Aug; (83):309-12. PubMed ID: 3071345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
    Hammond WP; Price TH; Souza LM; Dale DC
    N Engl J Med; 1989 May; 320(20):1306-11. PubMed ID: 2469956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.
    Greenberg P; Negrin R; Nagler A; Vincent M; Donlon T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():293-300; discussion 300-2. PubMed ID: 1691248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effect of recombinant human granulocyte colony-stimulating factor in bone marrow transplantation. The Japan rhG-CSF Clinical Study Group].
    Asano S; Masaoka T; Takaku F
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1201-9. PubMed ID: 1693489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy.
    Eguchi K; Sasaki S; Tamura T; Sasaki Y; Shinkai T; Yamada K; Soejima Y; Fukuda M; Fujihara Y; Kunitou H
    Cancer Res; 1989 Sep; 49(18):5221-4. PubMed ID: 2475245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
    Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
    Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
    Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic idiopathic neutropenia improved by recombinant granulocyte colony stimulating factor].
    Kojima H; Hasegawa Y; Shibuya K; Nakazawa M; Yoda Y; Abe T
    Rinsho Ketsueki; 1990 Feb; 31(2):189-93. PubMed ID: 1691794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
    Takeshita A; Ohno R; Hirashima K; Toyama K; Okuma M; Saito H; Ikeda Y; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):606-14. PubMed ID: 7543956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Vadhan-Raj S; Keating M; LeMaistre A; Hittelman WN; McCredie K; Trujillo JM; Broxmeyer HE; Henney C; Gutterman JU
    N Engl J Med; 1987 Dec; 317(25):1545-52. PubMed ID: 3500414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
    Nemunaitis J; Rabinowe SN; Singer JW; Bierman PJ; Vose JM; Freedman AS; Onetto N; Gillis S; Oette D; Gold M
    N Engl J Med; 1991 Jun; 324(25):1773-8. PubMed ID: 1903847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia.
    Castleberry RP; Emanuel PD; Zuckerman KS; Cohn S; Strauss L; Byrd RL; Homans A; Chaffee S; Nitschke R; Gualtieri RJ
    N Engl J Med; 1994 Dec; 331(25):1680-4. PubMed ID: 7605422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy for acute leukemias at higher age or after relapse.
    Büchner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig WD
    Haematol Blood Transfus; 1990; 33():724-31. PubMed ID: 2182462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic growth factor (G-CSF or GM-CSF) after salvage chemotherapy in refractory or relapsed adult de novo acute leukemia.
    Martino R; Brunet S; Sureda A; Guàrdia R; Aventiín A; Soler J; Altés A; Domingo-Albós A
    Leuk Lymphoma; 1996 Jan; 20(3-4):321-6. PubMed ID: 8624474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study.
    Ohno R; Miyawaki S; Hatake K; Kuriyama K; Saito K; Kanamaru A; Kobayashi T; Kodera Y; Nishikawa K; Matsuda S; Yamada O; Omoto E; Takeyama H; Tsukuda K; Asou N; Tanimoto M; Shiozaki H; Tomonaga M; Masaoka T; Miura Y; Takaku F; Ohashi Y; Motoyoshi K
    J Clin Oncol; 1997 Aug; 15(8):2954-65. PubMed ID: 9256140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.